HHS Relabels Invalidated 340b Regulation As “Interpretative Rule”
By EsqSocial Corporation 24/07/14
Earlier this week HHS came out swinging in the latest round of its battle with the Pharmaceutical Research & Manufacturers of America (PhRMA) over the Affordable Care Act’s provisions on 340B and orphan drugs. HHS reasserted its long-held position...
By: Faegre Baker Daniels